Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum

Regulation of IL-17 in atherosclerosis and related autoimmunity

(2015) Heeju Ryu et al.   CYTOKINE

Sex hormones in male psoriasis patients and their correlation with the Psoriasis Area and Severity Index

(2015) Bengu C. Cemil et al.   JOURNAL OF DERMATOLOGY

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study

(2015) A.B. Kimball et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

(2015) C.C. Zouboulis et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psychophysical Aspects of Hidradenitis Suppurativa

(2014) Ł Matusiak et al.   ACTA DERMATO-VENEREOLOGICA

Use of biological treatments in patients with hidradenitis suppurativa

(2014) G. Martin-Ezquerra et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Association of Metabolic Syndrome and Hidradenitis Suppurativa

(2014) Iben Marie Miller et al.   JAMA Dermatology

Management of Recalcitrant Hidradenitis Suppurativa with Ustekinumab

(2013) V Sharon et al.   ACTA DERMATO-VENEREOLOGICA

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

(2013) Alexa B. Kimball et al.   ANNALS OF INTERNAL MEDICINE

Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?

(2013) C.W. Wieland et al.   BRITISH JOURNAL OF DERMATOLOGY

Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support

(2013) F.W. Danby et al.   BRITISH JOURNAL OF DERMATOLOGY

Haplotypes of IL-12Rβ1 impact on the clinical phenotype of hidradenitis suppurativa

(2013) Sophia Giatrakos et al.   CYTOKINE

Successful long-term triple disease control by ustekinumab in a patient with Behçet's disease, psoriasis and hidradenitis suppurativa: Table 1

(2012) Ewout M Baerveldt et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa

(2012) A. Savva et al.   BRITISH JOURNAL OF DERMATOLOGY

Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review

(2012) J.L. Blok et al.   BRITISH JOURNAL OF DERMATOLOGY

Discovery and mechanism of ustekinumab

(2012) Jacqueline M. Benson et al.   mAbs

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

(2012) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa

(2011) Dominique C. van Rappard et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Interpretation of Skindex-29 Scores: Cutoffs for Mild, Moderate, and Severe Impairment of Health-Related Quality of Life

(2011) Cecilia A.C. Prinsen et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa

(2011) Christoph Schlapbach et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa

(2011) W.P. Gulliver et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme

(2011) R. J. Snelgrove   THORAX

Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging

(2009) Łukasz Matusiak et al.   BIOMARKERS

Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity

(2009) K. Sartorius et al.   BRITISH JOURNAL OF DERMATOLOGY

Hidradenitis suppurativa: A comprehensive review

(2009) Ali Alikhan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hidradenitis suppurativa

(2009) J Revuz   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET